These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 24436155)

  • 1. Enterolactone concentrations and prognosis after postmenopausal breast cancer: assessment of effect modification and meta-analysis.
    Seibold P; Vrieling A; Johnson TS; Buck K; Behrens S; Kaaks R; Linseisen J; Obi N; Heinz J; Flesch-Janys D; Chang-Claude J
    Int J Cancer; 2014 Aug; 135(4):923-33. PubMed ID: 24436155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating enterolactone concentrations and prognosis of postmenopausal breast cancer: assessment of mediation by inflammatory markers.
    Jaskulski S; Jung AY; Behrens S; Johnson T; Kaaks R; Thöne K; Flesch-Janys D; Sookthai D; Chang-Claude J
    Int J Cancer; 2018 Dec; 143(11):2698-2708. PubMed ID: 29974464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum enterolactone and prognosis of postmenopausal breast cancer.
    Buck K; Vrieling A; Zaineddin AK; Becker S; Hüsing A; Kaaks R; Linseisen J; Flesch-Janys D; Chang-Claude J
    J Clin Oncol; 2011 Oct; 29(28):3730-8. PubMed ID: 21900115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-diagnostic plasma enterolactone concentrations and breast cancer prognosis among postmenopausal women - The Danish Diet, Cancer and Health cohort.
    Kyrø C; Hansen L; Frederiksen K; Nørskov NP; Bach Knudsen KE; Eriksen AK; Holm M; Tjønneland A; Olsen A
    Clin Nutr; 2018 Dec; 37(6 Pt A):2217-2225. PubMed ID: 29154112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediagnostic plasma enterolactone levels and mortality among women with breast cancer.
    Olsen A; Christensen J; Knudsen KE; Johnsen NF; Overvad K; Tjønneland A
    Breast Cancer Res Treat; 2011 Aug; 128(3):883-9. PubMed ID: 21340481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum enterolactone levels and mortality outcome in women with early breast cancer: a retrospective cohort study.
    Guglielmini P; Rubagotti A; Boccardo F
    Breast Cancer Res Treat; 2012 Apr; 132(2):661-8. PubMed ID: 22094938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum enterolactone and postmenopausal breast cancer risk by estrogen, progesterone and herceptin 2 receptor status.
    Zaineddin AK; Vrieling A; Buck K; Becker S; Linseisen J; Flesch-Janys D; Kaaks R; Chang-Claude J
    Int J Cancer; 2012 Mar; 130(6):1401-10. PubMed ID: 21544804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic associations of circulating phytoestrogens and biomarker changes in long-term survivors of postmenopausal breast cancer.
    Jaskulski S; Jung AY; Huebner M; Poschet G; Hell R; Hüsing A; Gonzalez-Maldonado S; Behrens S; Obi N; Becher H; Chang-Claude J
    Nutr Cancer; 2020; 72(7):1155-1169. PubMed ID: 31617773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma enterolactone and breast cancer incidence by estrogen receptor status.
    Olsen A; Knudsen KE; Thomsen BL; Loft S; Stripp C; Overvad K; Møller S; Tjønneland A
    Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2084-9. PubMed ID: 15598765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma enterolactone and genistein and the risk of premenopausal breast cancer.
    Piller R; Chang-Claude J; Linseisen J
    Eur J Cancer Prev; 2006 Jun; 15(3):225-32. PubMed ID: 16679865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum enterolactone and risk of breast cancer: a case-control study in eastern Finland.
    Pietinen P; Stumpf K; Männistö S; Kataja V; Uusitupa M; Adlercreutz H
    Cancer Epidemiol Biomarkers Prev; 2001 Apr; 10(4):339-44. PubMed ID: 11319174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating 25-hydroxyvitamin D and postmenopausal breast cancer survival: Influence of tumor characteristics and lifestyle factors?
    Vrieling A; Seibold P; Johnson TS; Heinz J; Obi N; Kaaks R; Flesch-Janys D; Chang-Claude J
    Int J Cancer; 2014 Jun; 134(12):2972-83. PubMed ID: 24272459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum enterolactone concentration is not associated with breast cancer risk in a nested case-control study.
    Kilkkinen A; Virtamo J; Vartiainen E; Sankila R; Virtanen MJ; Adlercreutz H; Pietinen P
    Int J Cancer; 2004 Jan; 108(2):277-80. PubMed ID: 14639615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genistein and enterolactone in relation to Ki-67 expression and HER2 status in postmenopausal breast cancer patients.
    Jaskulski S; Jung AY; Rudolph A; Johnson T; Thöne K; Herpel E; Sinn P; Chang-Claude J
    Mol Nutr Food Res; 2017 Nov; 61(11):. PubMed ID: 28734033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating enterolactone and risk of endometrial cancer.
    Zeleniuch-Jacquotte A; Lundin E; Micheli A; Koenig KL; Lenner P; Muti P; Shore RE; Johansson I; Krogh V; Lukanova A; Stattin P; Afanasyeva Y; Rinaldi S; Arslan AA; Kaaks R; Berrino F; Hallmans G; Toniolo P; Adlercreutz H
    Int J Cancer; 2006 Nov; 119(10):2376-81. PubMed ID: 16929490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediagnosis plasma concentrations of enterolactone and survival after colorectal cancer: the Danish Diet, Cancer and Health cohort.
    Kyrø C; Frederiksen K; Holm M; Nørskov NP; Knudsen KEB; Overvad K; Tjønneland A; Olsen A
    Br J Nutr; 2019 Sep; 122(5):552-563. PubMed ID: 30173678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma levels of enterolactone and percentage mammographic density among postmenopausal women.
    Stuedal A; Gram IT; Bremnes Y; Adlercreutz H; Veierød MB; Ursin G
    Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2154-9. PubMed ID: 16172225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma enterolactone and breast cancer risk in the Nurses' Health Study II.
    Xie J; Tworoger SS; Franke AA; Terry KL; Rice MS; Rosner BA; Willett WC; Hankinson SE; Eliassen AH
    Breast Cancer Res Treat; 2013 Jun; 139(3):801-9. PubMed ID: 23760859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of cardiovascular disease-related and all-cause death according to serum concentrations of enterolactone: Kuopio Ischaemic Heart Disease Risk Factor Study.
    Vanharanta M; Voutilainen S; Rissanen TH; Adlercreutz H; Salonen JT
    Arch Intern Med; 2003 May; 163(9):1099-104. PubMed ID: 12742810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma enterolactone and incidence of endometrial cancer in a case-cohort study of Danish women.
    Aarestrup J; Kyrø C; Knudsen KE; Weiderpass E; Christensen J; Kristensen M; Würtz AM; Johnsen NF; Overvad K; Tjønneland A; Olsen A
    Br J Nutr; 2013 Jun; 109(12):2269-75. PubMed ID: 23114205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.